US Stock MarketDetailed Quotes

ELAN Elanco Animal Health

Watchlist
  • 9.510
  • +0.050+0.53%
Close Apr 28 16:00 ET
4.72BMarket Cap13.99P/E (TTM)

About Elanco Animal Health Company

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Greenfield, IN.

Company Profile

SymbolELAN
Company NameElanco Animal Health
Listing DateSep 20, 2018
Issue Price24.00
Founded1954
CEOMr. Jeffrey N. Simmons
MarketNYSE
Employees9450
Fiscal Year Ends12-31
Address2500 Innovation Way
CityGreenfield
ProvinceIndiana
CountryUnited States of America
Zip Code46140
Phone1-877-352-6261

Company Executives

  • Name
  • Position
  • Salary
  • Jeffrey N. Simmons
  • President, Chief Executive Officer and Director
  • 14.83M
  • Todd S. Young
  • Executive Vice President and Chief Financial Officer
  • 4.11M
  • James M. Meer
  • Senior Vice President and Chief Accounting Officer
  • --
  • Shiv O'Neill
  • Executive Vice President, General Counsel and Corporate Secretary
  • --
  • Grace McArdle
  • Executive Vice President, Manufacturing and Quality
  • --
  • Ellen de Brabander, PhD
  • Executive Vice President, Innovation and Regulatory Affairs
  • 3.91M
  • Timothy J. Bettington
  • Executive Vice President, Corporate Strategy and Market Development
  • 2.53M
  • Ramiro Martin Cabral
  • Executive Vice President and President of Elanco International
  • 2.94M
  • Rajeev A. Modi
  • Executive Vice President, U.S. Pet Health and Global Digital Transformation
  • --
  • Jose Manuel Correia de Simas, PhD
  • Executive Vice President, U.S. Farm Animal Business
  • --
  • David S. Kinard
  • Executive Vice President, Human Resources, Corporate Communications and Administration
  • --
  • Lawrence E. Kurzius
  • Chairman of the Board
  • 426.08K
  • Kathy V. Turner
  • Independent Director
  • 250.30K
  • John P. Bilbrey
  • Independent Director
  • 346.01K
  • Craig Wallace
  • Independent Director
  • 250.30K
  • Kapila Kapur Anand
  • Independent Director
  • 355.01K
  • R. David Hoover
  • Independent Director
  • 398.88K
  • Paul S. Herendeen
  • Independent Director
  • 330.01K
  • Michael J. Harrington
  • Independent Director
  • 339.38K
  • Kirk McDonald
  • Independent Director
  • 341.72K
  • Art A. Garcia
  • Independent Director
  • 330.01K
  • Dr. Stacey Ma, PhD
  • Independent Director
  • 46.01K
  • Dr. Denise Vera Scots-Knight, PhD
  • Independent Director
  • 330.01K
  • Dr. Deborah T. Kochevar, D.V.M.,PhD
  • Independent Director
  • 346.01K

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More